TY - JOUR
T1 - Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)
AU - García Morales, Olga M.
AU - Rojas-Reyes, Maria Ximena
AU - Dennis, Rodolfo J.
N1 - Funding Information:
This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Airways. The views and opinions expressed therein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health.
Publisher Copyright:
© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2017/8/3
Y1 - 2017/8/3
N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy and safety of adding oral theophylline or doxofylline to usual treatment (long-acting beta2-agonists, antimuscarinics, inhaled corticosteroids) versus providing usual treatment alone for patients with stable COPD.
AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy and safety of adding oral theophylline or doxofylline to usual treatment (long-acting beta2-agonists, antimuscarinics, inhaled corticosteroids) versus providing usual treatment alone for patients with stable COPD.
UR - http://www.scopus.com/inward/record.url?scp=85028375609&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028375609&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD012748
DO - 10.1002/14651858.CD012748
M3 - Article
AN - SCOPUS:85028375609
SN - 1465-1858
VL - 2017
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 8
M1 - CD012748
ER -